Published in J Biol Chem on October 15, 1993
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med (2015) 5.51
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A (2011) 3.87
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J (2003) 3.35
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48
Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell (2004) 2.21
CFTR: folding, misfolding and correcting the ΔF508 conformational defect. Trends Mol Med (2011) 1.99
DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest (1999) 1.97
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis. Sci Transl Med (2014) 1.67
Processing and function of CFTR-DeltaF508 are species-dependent. Proc Natl Acad Sci U S A (2007) 1.62
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling. Biochemistry (2008) 1.50
Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect. PLoS Biol (2016) 1.42
The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells. J Biol Chem (2009) 1.40
Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol (2009) 1.37
Endocytic trafficking of CFTR in health and disease. J Cyst Fibros (2006) 1.36
Three distinct structural environments of a transmembrane domain in the inwardly rectifying potassium channel ROMK1 defined by perturbation. Proc Natl Acad Sci U S A (1995) 1.35
COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments. J Cell Biol (2001) 1.32
Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle. Proc Natl Acad Sci U S A (2013) 1.30
Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28
Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J (1997) 1.26
Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency. EMBO J (1995) 1.21
Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. Autophagy (2014) 1.21
Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. J Clin Invest (2002) 1.20
Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harb Perspect Med (2013) 1.20
Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun (2007) 1.13
A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR. Angew Chem Int Ed Engl (2010) 1.13
NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J (2009) 1.12
Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells. Am J Respir Cell Mol Biol (2009) 1.12
CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium. J Clin Invest (1995) 1.10
Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells. Biochem J (1997) 1.05
Thermally unstable gating of the most common cystic fibrosis mutant channel (ΔF508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops. J Biol Chem (2011) 1.04
The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR. J Physiol (2011) 1.04
Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs. J Biol Chem (2010) 1.03
Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Ther (2009) 1.02
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR. J Physiol (2014) 1.00
Protein quality control at the plasma membrane. Curr Opin Cell Biol (2011) 0.99
Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling. Am J Physiol Cell Physiol (2011) 0.98
Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization. J Biol Chem (2015) 0.97
Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies. Curr Mol Med (2010) 0.95
Regulation of CFTR trafficking by its R domain. J Biol Chem (2008) 0.95
Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR. Cell Physiol Biochem (2009) 0.94
Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein. J Bioenerg Biomembr (1997) 0.94
Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms. J Biol Chem (2009) 0.93
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell (2016) 0.92
Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels. J Biol Chem (2012) 0.92
Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells. Mol Biol Cell (2009) 0.91
The connexin turnover, an important modulating factor of the level of cell-to-cell junctional communication: comparison with other integral membrane proteins. J Membr Biol (2007) 0.91
Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains. Protein Sci (2014) 0.91
∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. Nature (2015) 0.90
Functional Rescue of F508del-CFTR Using Small Molecule Correctors. Front Pharmacol (2012) 0.90
Fixing cystic fibrosis by correcting CFTR domain assembly. J Cell Biol (2012) 0.90
Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors. Mol Ther Nucleic Acids (2013) 0.89
Interplay between ER exit code and domain conformation in CFTR misprocessing and rescue. Mol Biol Cell (2009) 0.89
The deubiquitinating enzyme USP10 regulates the endocytic recycling of CFTR in airway epithelial cells. Channels (Austin) (2011) 0.89
Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator. Expert Rev Proteomics (2010) 0.89
Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis. Acta Pharmacol Sin (2011) 0.88
Rescue of epithelial HCO3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del. J Physiol (2012) 0.88
Stabilizing rescued surface-localized δf508 CFTR by potentiation of its interaction with Na(+)/H(+) exchanger regulatory factor 1. Biochemistry (2014) 0.88
Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect. Proc Natl Acad Sci U S A (2011) 0.87
New and emerging targeted therapies for cystic fibrosis. BMJ (2016) 0.87
CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR. Br J Pharmacol (2014) 0.86
Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor). Br J Pharmacol (2016) 0.85
Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1. Br J Pharmacol (2011) 0.85
Low abundance of sweat duct Cl- channel CFTR in both healthy and cystic fibrosis athletes with exceptionally salty sweat during exercise. Am J Physiol Regul Integr Comp Physiol (2011) 0.85
Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect. Front Pharmacol (2013) 0.84
A truncated CFTR protein rescues endogenous DeltaF508-CFTR and corrects chloride transport in mice. FASEB J (2009) 0.84
Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator. J Biol Chem (2012) 0.84
Cystic fibrosis transmembrane conductance regulator (CFTR) potentiators protect G551D but not ΔF508 CFTR from thermal instability. Biochemistry (2014) 0.83
Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation. Expert Rev Precis Med Drug Dev (2016) 0.82
Ion channel associated diseases: overview of molecular mechanisms. Chem Rev (2012) 0.82
Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation. PLoS One (2015) 0.81
Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity. PLoS One (2015) 0.80
Pharmacological Correctors of Mutant CFTR Mistrafficking. Front Pharmacol (2012) 0.79
Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis. Front Pharmacol (2012) 0.79
On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator. J Physiol (2016) 0.79
Targeted therapies to improve CFTR function in cystic fibrosis. Genome Med (2015) 0.79
Folding and rescue of a cystic fibrosis transmembrane conductance regulator trafficking mutant identified using human-murine chimeric proteins. J Biol Chem (2010) 0.78
delta F508 in cystic fibrosis: willing but not able. Arch Dis Child (1997) 0.78
Rescuing ΔF508 CFTR with trimethylangelicin, a dual-acting corrector and potentiator. Am J Physiol Lung Cell Mol Physiol (2014) 0.78
Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating. J Physiol (2015) 0.78
Protein homeostasis at the plasma membrane. Physiology (Bethesda) (2014) 0.78
Development of CFTR Structure. Front Pharmacol (2012) 0.77
Enhancing the Potency of F508del Correction: A Multi-Layer Combinational Approach to Drug Discovery for Cystic Fibrosis. J Pharmacol Clin Toxicol (2013) 0.77
Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy. Am J Physiol Lung Cell Mol Physiol (2016) 0.77
Molecular motors and apical CFTR traffic in epithelia. Int J Mol Sci (2013) 0.77
Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27. J Biol Chem (2015) 0.76
The ΔF508-CFTR mutation inhibits wild-type CFTR processing and function when co-expressed in human airway epithelia and in mouse nasal mucosa. BMC Physiol (2012) 0.76
Interaction non grata between CFTR's correctors and potentiators. Ann Transl Med (2015) 0.76
Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry. Chembiochem (2015) 0.76
S-palmitoylation regulates biogenesis of core glycosylated wild-type and F508del CFTR in a post-ER compartment. Biochem J (2014) 0.76
Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences. Biomed Res Int (2016) 0.76
Improvement of chloride transport defect by gonadotropin-releasing hormone (GnRH) in cystic fibrosis epithelial cells. PLoS One (2014) 0.76
Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds. Br J Pharmacol (2017) 0.75
Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia. NPJ Genom Med (2017) 0.75
Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function. Front Pharmacol (2017) 0.75
Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines. PLoS One (2016) 0.75
Stable, polarised, functional expression of Kir1.1b channel protein in Madin-Darby canine kidney cell line. J Physiol (2000) 0.75
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell (1995) 5.61
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell (1992) 4.71
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27
Concentration of viruses from sewage and excreta on insoluble polyelectrolytes. Appl Microbiol (1969) 4.17
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (1985) 3.97
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (1983) 3.88
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol (2001) 3.63
Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature (1991) 3.61
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (1985) 3.59
Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science (1985) 3.43
The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature (1998) 3.41
Virus isolations from sewage and from a stream receiving effluents of sewage treatment plants. Bull World Health Organ (1970) 3.27
Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene (2008) 2.94
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem (1993) 2.85
Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med (1999) 2.81
Mechanisms of regulation of the Na+/H+ exchanger. J Membr Biol (1986) 2.72
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65
Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet (1992) 2.64
Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J (1998) 2.55
Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat Struct Biol (1998) 2.49
Comparison of filler DNA at immune, nonimmune, and oncogenic rearrangements suggests multiple mechanisms of formation. Mol Cell Biol (1989) 2.30
Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med (2000) 2.28
Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J Cell Biol (2001) 2.28
Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1994) 2.27
Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26
Cytoplasmic pH regulation in thymic lymphocytes by an amiloride-sensitive Na+/H+ antiport. J Gen Physiol (1984) 2.23
Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature (1997) 2.21
Na+/H+ exchangers of mammalian cells. J Biol Chem (1997) 2.12
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol (1985) 2.12
Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation. J Cell Biol (2000) 2.10
The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils. Mol Cell Biol (1998) 2.10
Phosphatidylinositol polyphosphate binding to the mammalian septin H5 is modulated by GTP. Curr Biol (2000) 2.09
DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol (1982) 2.03
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem (1979) 1.98
Phagosomal acidification is mediated by a vacuolar-type H(+)-ATPase in murine macrophages. J Biol Chem (1990) 1.94
Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther (1985) 1.92
A precision measurement of the mass of the top quark. Nature (2004) 1.87
Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J Biol Chem (1991) 1.86
Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis (1989) 1.82
MSP RFLP for X-linked proteolipid protein gene (PLP) identified with either rat or human PLP cDNA clone. Nucleic Acids Res (1987) 1.80
Mechanism of acidification of the trans-Golgi network (TGN). In situ measurements of pH using retrieval of TGN38 and furin from the cell surface. J Biol Chem (1998) 1.78
Volume-induced increase of anion permeability in human lymphocytes. J Gen Physiol (1982) 1.78
Multidrug resistance. Cancer Surv (1986) 1.75
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates. J Gen Physiol (1993) 1.74
Transmembrane ion fluxes during activation of human T lymphocytes: role of Ca2+, Na+/H+ exchange and phospholipid turnover. Immunol Rev (1987) 1.74
Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J Biol Chem (1997) 1.74
Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med (1998) 1.73
Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep (1983) 1.72
A pH-sensitive and voltage-dependent proton conductance in the plasma membrane of macrophages. J Gen Physiol (1993) 1.71
The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun (1986) 1.71
Rho is required for the initiation of calcium signaling and phagocytosis by Fcgamma receptors in macrophages. J Exp Med (1997) 1.71
Responses of lymphocytes to anisotonic media: volume-regulating behavior. Am J Physiol (1984) 1.69
Cytoplasmic pH regulation in phorbol ester-activated human neutrophils. Am J Physiol (1986) 1.68
Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor. J Cell Biol (1996) 1.67
Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem (1996) 1.66
Use of clinical audit for revalidation: is it sufficiently accurate? J Qual Clin Pract (2001) 1.65
P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol (1987) 1.64
Phagosomal maturation, acidification, and inhibition of bacterial growth in nonphagocytic cells transfected with FcgammaRIIA receptors. J Biol Chem (1999) 1.63
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites. J Gen Physiol (1999) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc Natl Acad Sci U S A (1998) 1.59
Volume regulation by human lymphocytes. Role of calcium. J Gen Physiol (1982) 1.58
Functional characterization of three isoforms of the Na+/H+ exchanger stably expressed in Chinese hamster ovary cells. ATP dependence, osmotic sensitivity, and role in cell proliferation. J Biol Chem (1994) 1.57
Proton currents in human granulocytes: regulation by membrane potential and intracellular pH. J Physiol (1993) 1.56
Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H+ "leak". J Biol Chem (1991) 1.54
Phorbol ester-induced actin assembly in neutrophils: role of protein kinase C. J Cell Biol (1992) 1.54
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res (1983) 1.53
The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med (1999) 1.53
Evidence for three-dimensional cortical control of gaze from epileptic patients. J Neurol Neurosurg Psychiatry (2009) 1.52
Regulation of phagosomal acidification. Differential targeting of Na+/H+ exchangers, Na+/K+-ATPases, and vacuolar-type H+-atpases. J Biol Chem (1997) 1.52
Intracellular pH regulation by Na(+)/H(+) exchange requires phosphatidylinositol 4,5-bisphosphate. J Cell Biol (2000) 1.52
Characterization of the activation of Na+/H+ exchange in lymphocytes by phorbol esters: change in cytoplasmic pH dependence of the antiport. Proc Natl Acad Sci U S A (1985) 1.50
Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor signalling during phagocytosis. J Cell Sci (2001) 1.48
Surveillance for rotavirus in Argentina. J Med Virol (2001) 1.47
v-SNARE-dependent secretion is required for phagocytosis. Proc Natl Acad Sci U S A (1998) 1.47
Protein kinase C activates an H+ (equivalent) conductance in the plasma membrane of human neutrophils. Proc Natl Acad Sci U S A (1991) 1.46